INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2012

Echinacea supplementation showed borderline significantly lower respiratory symptom scores during travel compared to placebo in long-haul air travellers.

A randomised, double-blind, placebo-controlled trial assessed whether a standardised Echinacea formulation prevents respiratory and other symptoms in 175 adults on long-haul flights. Participants took Echinacea (root extract, standardised to 4.4 mg alkylamides) or placebo tablets and were surveyed before, immediately after, and 4 weeks after travel. Respiratory symptoms increased significantly during travel in both groups (P < 0.0005). However, the Echinacea group demonstrated borderline significantly lower respiratory symptom scores compared to placebo during travel (P = 0.05).

Study type
Randomised, double-blind, placebo-controlled trial
Who was studied
175 adults travelling from Australia to America, Europe, or Africa for 1-5 weeks
What was measured
Upper respiratory symptoms and travel-related quality of life

THE PAPER

Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellers.

Tiralongo E, Lea RA, Wee SS, Hanna MM, Griffiths LR. Evid Based Complement Alternat Med, 2012.

PubMed 22229040 ↗DOI 10.1155/2012/417267 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.